JPH08294532A - Prefilled syringe - Google Patents

Prefilled syringe

Info

Publication number
JPH08294532A
JPH08294532A JP7125964A JP12596495A JPH08294532A JP H08294532 A JPH08294532 A JP H08294532A JP 7125964 A JP7125964 A JP 7125964A JP 12596495 A JP12596495 A JP 12596495A JP H08294532 A JPH08294532 A JP H08294532A
Authority
JP
Japan
Prior art keywords
gasket
syringe
closing body
outer cylinder
injection needle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP7125964A
Other languages
Japanese (ja)
Other versions
JP3419145B2 (en
Inventor
Jun Futagawa
準 二川
Hideki Yagi
秀樹 八木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissho Corp
Original Assignee
Nissho Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissho Corp filed Critical Nissho Corp
Priority to JP12596495A priority Critical patent/JP3419145B2/en
Publication of JPH08294532A publication Critical patent/JPH08294532A/en
Application granted granted Critical
Publication of JP3419145B2 publication Critical patent/JP3419145B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M2005/1787Syringes for sequential delivery of fluids, e.g. first medicament and then flushing liquid

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

PURPOSE: To provide a prefilled syringe usable as a two-pack type and a one- pack type as well by providing the inside of the outside cylinder of a syringe with a front part gasket contg. a closing body, a rear part gasket freely mountable with a plunger and a closing body extruding means mounted at the rear end of an injection needle mounting member. CONSTITUTION: The plunger 9 is pushed forward while the distance between the front part gasket 5 and the rear part gasket 7 is maintained and a liquid medicine (x) is injected from the hypodermic needle 8 when the plunger 9 is pushed at the time of use in the case the medicinal liquids (x), (y) are used. The front part gasket 5 exists at the front end of the outside cylinder 1 of the syringe and the closing body 6 in the front part gasket 5 comes into contact with a closing body extruding member 3 when the medicinal liquid (x) is discharged. Only the front part gasket 5 advances and the bypass path of the front part gasket 5 is communicated with the medicinal liquid passage of the hypodermic needle mounting part 2 through the opening 31 of the closing body extruding member 3 when the plunger 9 is further pushed from this state. The medicinal liquid (y) is then discharged from the injection needle 8.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明はプレフィルドシリンジに
関する。さらに詳しくは、病院等で薬液を投与するのに
用いられる注射器であり、予め薬液を充填しておいて用
時に直ちに使用できるようにしたプレフィルドシリンジ
に関する。
FIELD OF THE INVENTION This invention relates to prefilled syringes. More specifically, the present invention relates to a prefilled syringe which is a syringe used for administering a medicinal solution in a hospital or the like, and which is preliminarily filled with the medicinal solution and ready to be used at the time of use.

【0002】[0002]

【従来の技術】プレフィルドシリンジには1液型と2液
型があるが、2液型のプレフィルドシリンジの従来技術
(従来例I)として、実公昭49−14465号公報や
特公平6−14756号公報に記載されたものがある。
これらのプレフィルドシリンジの基本的な構成は、図9
に示すように、シリンジ外筒151 の中央部内壁にバイパ
ス路152 を凹設し、プランジャー153 を押し込んだと
き、ガスケット154 とプランジャー153 の間の液B(例
えば溶解液)がガスケット154 より前方にバイパス溝15
2 を通って進入し、乾燥薬剤A(例えば抗生剤)と混合
されるようになっている。また、1液型のプレフィルド
シリンジの従来技術(従来例II)として、特開昭49−
68586号公報や実公昭52−38067号公報、実
開昭58−126839号公報に記載されたものがあ
る。特開昭49−68586号公報のものを代表させて
説明すると、図10に示すように、シリンジaの先端に両
頭針pをキャップ201 で取付け、プランジャーcを押し
込むとゴム栓(ダイヤフラム)204 が穿刺されて、充填
していた薬液gを両頭針pを通して注射できるようにな
っている。上記の2液型の従来例Iおよび1液型の従来
例IIは、いずれも用時まではゴム栓で密封して薬液を保
存しておき、用時には両頭針でゴム栓を穿刺する点で共
通している。
2. Description of the Related Art There are one-pack type and two-pack type prefilled syringes, but as a conventional technique (conventional example I) of a two-pack type prefilled syringe, Japanese Utility Model Publication No. 49-14465 and Japanese Patent Publication No. 6-14756. Some are described in the official gazette.
The basic configuration of these prefilled syringes is shown in FIG.
As shown in FIG. 5, when the bypass passage 152 is recessed in the inner wall of the central portion of the syringe outer cylinder 151 and the plunger 153 is pushed in, the liquid B (for example, the dissolution liquid) between the gasket 154 and the plunger 153 is generated by the gasket 154. Bypass groove 15 in front
It enters through 2 and is mixed with dry drug A (eg, antibiotic). Further, as a conventional technique (conventional example II) for a one-pack type prefilled syringe, Japanese Patent Laid-Open No. 49-
68586, JP-B-52-38067 and JP-B-58-126839. A description will be given with the one disclosed in JP-A-49-68586 as a representative. As shown in FIG. 10, when a double-ended needle p is attached to the tip of a syringe a with a cap 201 and a plunger c is pushed in, a rubber plug (diaphragm) 204 is attached. Is punctured, and the filled drug solution g can be injected through the double-ended needle p. In both the two-component type conventional example I and the one-component type conventional example II, the drug solution is stored by sealing with a rubber stopper until the time of use, and the rubber stopper is punctured with a double-ended needle at the time of use. Have in common.

【0003】[0003]

【発明が解決しようとする課題】しかるに上記の従来例
I、IIではつぎのような問題があった。従来例Iでは、
シリンジ外筒151 のバイパス溝152 の加工が困難であ
り、製造コストが高くつき、また大容量タイプはプレフ
ィルドシリンジの外筒はガラス容器であるため加工が困
難であり実現性に乏しいという問題がある。従来例IIで
は、両頭針でゴム栓を穿刺した場合に生じるコアリング
が不可避であり、コアリングにより注射液中に異物が混
入するとという問題がある。また、金属製の両頭針を用
いたものの場合は、予め金属針が接着剤等で固定された
ものもあり、シリンジ本体と両頭針を区別して廃棄する
分別廃棄ができないという問題がある。
However, the above-mentioned conventional examples I and II have the following problems. In Conventional Example I,
There is a problem that the bypass groove 152 of the syringe outer cylinder 151 is difficult to process and the manufacturing cost is high, and the pre-filled syringe outer cylinder of the large-capacity type is a glass container, which is difficult to process and is not feasible. . In Conventional Example II, coring that occurs when a rubber stopper is punctured with a double-ended needle is unavoidable, and there is a problem that foreign matter is mixed into the injection solution by the coring. Further, in the case of using a metal double-ended needle, there is a problem that the metal needle is fixed in advance with an adhesive or the like, and there is a problem that the syringe body and the double-ended needle cannot be separately discarded for separate disposal.

【0004】本発明は、かかる事情に鑑み、製造が容易
で低コストであり、大容量タイプも製造可能であり、コ
アリングが全く生じず、注射針の分別廃棄も可能なプレ
フィルドシリンジを提供することを目的とする。また、
従来のプレフィルドシリンジは2液型も1液型もそれぞ
れ専用品であり兼用できるものはなかったが、本発明は
2液型としても1液型としても利用できる兼用型のプレ
フィルドシリンジを提供することを目的とする。
In view of such circumstances, the present invention provides a prefilled syringe which is easy and inexpensive to manufacture, is capable of manufacturing a large-capacity type, has no coring, and is capable of separating and discarding injection needles. The purpose is to Also,
The conventional prefilled syringes, both of which are a two-component type and a one-component type, have no special purpose and cannot be used in common, but the present invention provides a dual-type prefilled syringe which can be used as a one-component type. With the goal.

【0005】[0005]

【課題を解決するための手段】本発明のプレフィルドシ
リンジは、両端が開口したシリンジ外筒と、前記シリン
ジ外筒の前端に設けられた注射針取付部材と、前記シリ
ンジ外筒の内部に液密に挿入された、閉鎖体を内蔵した
前部ガスケットと、前記シリンジ外筒の後端部に液密に
挿入された、プランジャーを取付自在な後部ガスケット
と、前記注射針取付部材の後端に取付けた閉鎖体押出手
段とからなり、前記前部ガスケットには、軸方向に貫通
する薬液通路と、該薬液通路の前方部に前記閉鎖体を収
容して該薬液通路を閉鎖する前方収容部と、該薬液通路
の後方部に前記閉鎖体を収容する後方収容部と、該後方
収容部を迂回し前記前方収容部と連通するバイパス路と
が形成されており、前記閉鎖体押出手段は、前記前部ガ
スケットがシリンジ外筒内の前端部に押し込まれたと
き、前部ガスケットの前方収容部内の前記閉鎖体に当接
して、これを後方収容部内に押し出す部材であることを
特徴とする。また、本発明では、シリンジ外筒の前端と
前部ガスケットの間に第1薬液を充填し、前部ガスケッ
トと後部ガスケットの間に第2薬液を充填して用いる2
液型のプレフィルドシリンジとして用いることもでき、
シリンジ外筒において前部ガスケットと後部ガスケット
の間に第1薬液のみを充填して用いる1液型のプレフィ
ルドシリンジとしても用いることができる。
A prefilled syringe of the present invention comprises a syringe outer cylinder having both ends open, an injection needle mounting member provided at the front end of the syringe outer cylinder, and a liquid-tight seal inside the syringe outer cylinder. The front gasket having a built-in closure body inserted thereinto, the rear gasket that is liquid-tightly inserted into the rear end of the syringe outer cylinder and on which the plunger can be attached, and the rear end of the injection needle attachment member. The front gasket includes a liquid passage extending axially through the front gasket, and a front accommodating portion for accommodating the closure at the front of the liquid passage to close the liquid passage. A rear accommodating portion for accommodating the closing body, and a bypass passage that bypasses the rear accommodating portion and communicates with the front accommodating portion, are formed in a rear portion of the liquid medicine passage, Front gasket When pushed into the front end of the outer cylinder, in contact with the closure body in the front housing portion of the front gasket, characterized in that it is a member for pushing the rear housing portion. Further, in the present invention, the first chemical liquid is filled between the front end of the syringe outer cylinder and the front gasket, and the second chemical liquid is filled between the front gasket and the rear gasket.
It can also be used as a liquid type prefilled syringe,
It can also be used as a one-liquid type prefilled syringe which is used by filling only the first chemical liquid between the front gasket and the rear gasket in the syringe outer cylinder.

【0006】[0006]

【作用】本発明では、注射針取付部材に任意の注射針を
取付け、後部ガスケットにプランジャーを結合して押し
込むと、前部ガスケットと後部ガスケットの間の薬液を
介して押し込み力が前部ガスケットに伝えられ、前部ガ
スケットがシリンジ外筒内の前端まで摺動する。この
間、前部ガスケット内の閉鎖体は前方収容部内に収容さ
れており前部ガスケット内の薬液通路を閉鎖している。
前部ガスケットがシリンジ外筒の前端まで到達したと
き、注射針取付部材の後端に取付けられている閉鎖体押
出手段の先端が閉鎖体に当接して、その閉鎖体を後方収
容部に移動させる。これによりバイパス路を通じて前部
ガスケットの薬液通路は開通するので、前部ガスケット
と後部ガスケット間の薬液の注射が可能となる。したが
って、2液型プレフィルドシリンジでは、初期の押し込
みによって第1薬液が注射され、つぎに上記のごとく前
部ガスケットの薬液通路が開通すると第2薬液が注射さ
れることになる。1液型プレフィルドシリンジでは前部
ガスケットの薬液通路の開通後、薬液が注射されること
になる。本発明においては、前部ガスケットによって薬
液の放出制御が行われるので、シリンジ外筒に従来例I
のようなバイパス溝を加工する必要がなく、このため加
工が容易であり、製造コストが低廉となる。また、筒状
体のシリンジ外筒を用いるので、大容量タイプの製造が
可能である。さらに、薬液通路内で閉鎖体を押し込むこ
とにより前部ガスケットが連通するので、注射針でゴム
栓を穿刺するようなコアリングが発生せず異物混入の余
地がない。また、両頭針を用いておらず、一般的な注射
針を取付自在にしているので注射針とシリンジ本体を区
別して廃棄する分別廃棄が可能となる。
According to the present invention, when an arbitrary injection needle is attached to the injection needle mounting member and the plunger is joined and pushed into the rear gasket, the pushing force is exerted through the liquid medicine between the front gasket and the rear gasket. The front gasket slides to the front end inside the syringe outer cylinder. During this time, the closing body in the front gasket is housed in the front housing part and closes the chemical liquid passage in the front gasket.
When the front gasket reaches the front end of the syringe outer cylinder, the tip of the closing body pushing means attached to the rear end of the injection needle attaching member abuts the closing body, and moves the closing body to the rear housing portion. . As a result, the chemical liquid passage of the front gasket is opened through the bypass passage, so that the chemical liquid can be injected between the front gasket and the rear gasket. Therefore, in the two-component type prefilled syringe, the first drug solution is injected by initial pushing, and then the second drug solution is injected when the drug solution passage of the front gasket is opened as described above. In the one-liquid type prefilled syringe, the drug solution is injected after the drug solution passage of the front gasket is opened. In the present invention, since the release of the drug solution is controlled by the front gasket, the conventional example I is attached to the syringe outer cylinder.
Since it is not necessary to process the bypass groove as described above, the processing is easy and the manufacturing cost is low. Moreover, since a cylindrical syringe outer cylinder is used, a large capacity type can be manufactured. Furthermore, since the front gasket is communicated by pushing the closing body in the drug solution passage, there is no room for foreign matter mixing because coring such as puncturing a rubber stopper with an injection needle does not occur. Further, since a double-headed needle is not used and a general injection needle is attachable, it is possible to separate and discard the injection needle and the syringe body separately.

【0007】[0007]

【実施例】つぎに、本発明の実施例を図面に基づき説明
する。図1は本発明の一実施例に係る2液型のプレフィ
ルドシリンジAの第1薬液注射操作の説明図、図2は同
プレフィルドシリンジAの前部ガスケット開栓操作の説
明図、図3は第2薬液注射操作の説明図、図4は注射完
了状態の説明図、図5は使用前の保管状態における同プ
レフィルドシリンジAの縦断面図である。
Embodiments of the present invention will now be described with reference to the drawings. 1 is an explanatory view of a first liquid medicine injection operation of a two-liquid type prefilled syringe A according to one embodiment of the present invention, FIG. 2 is an explanatory view of a front gasket opening operation of the same prefilled syringe A, and FIG. 2 is an explanatory view of the injection operation of the drug solution, FIG. 4 is an explanatory view of the injection completed state, and FIG.

【0008】まず、図5に基づき使用前の保管状態にお
けるプレフィルドシリンジAの構成を説明する。1はシ
リンジ外筒で、ガラス製で両端が開口した円筒状部材で
あり、先端部外周と後端部外周には環状突起11,12 が形
成されている。このシリンジ外筒1の前端には注射針取
付部材2が取付けられている。注射針取付部材2は円板
状の天面21とこの天面21の外周に形成したスカート部22
を有し、このスカート部22の下端円周には内側に突出す
る係合突起23が形成されている。この係合突起23がシリ
ンジ外筒1の環状突起11に係合して、注射針取付部材2
はシリンジ外筒1に強固に取付けられ、かつシリンジ外
筒1の前端を液密に封止する。なお、必要ならばシリン
ジ外筒1の前端と注射針取付部材2の間にパッキンを介
在させてもよい。また、天面21の中心位置から外側に突
出するようにルアーチップ24が形成され、その外側に同
心状に注射針の根元の螺合ネジをねじ込むための雌ネジ
筒25が形成されている。なお、ルアーチップ24と注射針
とをしまり嵌めで結合する嵌合タイプでもよく、その場
合は、前記雌ネジ筒25は不要である。本発明では上記ル
アーチップ24を用いたことにより任意の種類の注射針を
利用できるという利点がある。
First, the structure of the prefilled syringe A in the storage state before use will be described with reference to FIG. Reference numeral 1 denotes a syringe outer cylinder, which is a cylindrical member made of glass and having both ends opened, and annular projections 11 and 12 are formed on the outer circumference of the front end and the outer circumference of the rear end. An injection needle attachment member 2 is attached to the front end of the syringe outer cylinder 1. The injection needle mounting member 2 has a disk-shaped top surface 21 and a skirt portion 22 formed on the outer periphery of the top surface 21.
The skirt portion 22 is formed with an engaging projection 23 projecting inward on the lower end circumference thereof. The engagement protrusion 23 engages with the annular protrusion 11 of the syringe outer cylinder 1, and the injection needle mounting member 2
Is firmly attached to the syringe outer cylinder 1, and liquid-tightly seals the front end of the syringe outer cylinder 1. If necessary, packing may be interposed between the front end of the syringe outer cylinder 1 and the injection needle mounting member 2. Further, a luer tip (24) is formed so as to project outward from the center position of the top surface (21), and a female screw cylinder (25) for concentrically screwing a screw thread at the base of the injection needle is formed on the outside thereof. A fitting type in which the lure tip 24 and the injection needle are tightly fitted together may be used. In that case, the female screw cylinder 25 is not necessary. The present invention has an advantage that any type of injection needle can be used by using the lure tip 24.

【0009】さらに前記天面21の中心位置から内側に突
出するように閉鎖体押出部材3が形成されている。この
押出部材3は後述する前部ガスケット5内の閉鎖体6を
閉鎖位置から開放位置へ押し出すためのものであり、そ
の先端部の側壁には薬液を通すための開口31(図示の例
ではスリットに形成されている)が形成されている。そ
して、ルアーチップ24と閉鎖体押出部材3を貫通させて
薬液通路27が形成されている。なお、前記注射針取付部
材2には、プレフィルドシリンジAの不使用保管時にル
アーチップ24と雌ネジ筒25の汚染を防止し、かつシリン
ジ外筒1内の薬液の漏洩を防止するためのゴムキャップ
26が被せられるようになっている。
Further, a closing body pushing member 3 is formed so as to project inward from the center position of the top surface 21. The push-out member 3 is for pushing out a closing body 6 in a front gasket 5 described later from a closed position to an open position, and an opening 31 (a slit in the example shown in the drawing) for passing a chemical solution is formed in a side wall of a tip end portion thereof. Is formed). A chemical liquid passage 27 is formed by penetrating the lure tip 24 and the closing body pushing member 3. It should be noted that the injection needle mounting member 2 has a rubber cap for preventing contamination of the luer tip 24 and the female screw cylinder 25 when the prefilled syringe A is not used and for preventing leakage of the drug solution in the syringe outer cylinder 1.
26 is supposed to be covered.

【0010】前記シリンジ外筒1の後端にはフランジ4
が取付けられている。このフランジ4は、嵌合筒部41と
手の人差指と中指を引っ掛けるフランジ部42と後述する
後端カバー44を係止するための係合筒部43とから構成さ
れている。後端カバー44はプレフィルドシリンジAの不
使用保管時に後述する後部ガスケット7の汚染を防止す
るために取付けられる筒状カバーである。
A flange 4 is provided at the rear end of the syringe outer cylinder 1.
Is installed. The flange 4 includes a fitting tubular portion 41, a flange portion 42 for hooking the index finger and the middle finger of the hand, and an engaging tubular portion 43 for locking a rear end cover 44 described later. The rear end cover 44 is a cylindrical cover that is attached to prevent the rear gasket 7 from being contaminated when the prefilled syringe A is not used and stored.

【0011】前記シリンジ外筒1内には前部ガスケット
5と後部ガスケット7が挿入されている。前部ガスケッ
ト5はゴム製の栓体51からなり、栓体51には軸方向に貫
通した薬液通路52が形成され、この薬液通路52の前方部
に閉鎖体6を収容する前方収容部53が形成され、後方部
に後方収容部54が形成されている。前記閉鎖体6はプラ
スチック等で製した弾丸状あるいは球状の部材で、当初
は前方収容部53に挿入されており、後述するごとく開栓
時には後方収容部54に移動し、前部ガスケット5の薬液
通路52の開通と閉鎖を制御するものである。前記後方収
容部54にはバイパス路55が形成され、このバイパス路55
は前部ガスケット5の後端から、前方収容部53と後方収
容部54の間の薬液通路52に通じている。したがって、閉
鎖体6が前方収容部53内に位置しているとき薬液通路52
は閉鎖され、閉鎖体6が後方収容部54内に移動するとバ
イパス路55と薬液通路52を通じて前部ガスケット5の前
後が連通することになる。前記後部ガスケット7は公知
のガスケットで、ゴム製の栓体71に後述するプランジャ
ーをねじ込むための雌ネジ部72を形成したものである。
A front gasket 5 and a rear gasket 7 are inserted in the syringe outer cylinder 1. The front gasket 5 is composed of a rubber stopper 51, and a chemical passage 52 that penetrates in the axial direction is formed in the stopper 51. A front accommodation portion 53 for accommodating the closing body 6 is formed in the front portion of the chemical passage 52. The rear housing portion 54 is formed in the rear portion. The closing body 6 is a bullet-shaped or spherical member made of plastic or the like, which is initially inserted in the front accommodation portion 53, and moves to the rear accommodation portion 54 when the stopper is opened, as will be described later, and the chemical solution of the front gasket 5 is added. It controls the opening and closing of the passage 52. A bypass passage 55 is formed in the rear accommodation portion 54, and the bypass passage 55 is formed.
Communicates from the rear end of the front gasket 5 to the chemical liquid passage 52 between the front accommodation portion 53 and the rear accommodation portion 54. Therefore, when the closing body 6 is located in the front accommodation portion 53, the chemical liquid passage 52
Is closed, and when the closing body 6 moves into the rear accommodating portion 54, the front and rear of the front gasket 5 communicate with each other through the bypass passage 55 and the chemical liquid passage 52. The rear gasket 7 is a known gasket, in which a female plug 72 for screwing a plunger described later is formed in a rubber stopper 71.

【0012】本実施例のプレフィルドシリンジAは2液
型であるので、図示のごとく、前部ガスケット5はシリ
ンジ外筒1内の略中央に挿入され、後部ガスケット7は
シリンジ外筒1の後端に挿入される。そして、前部ガス
ケット5と注射針取付部材2との間が第1液室Xとな
り、第1薬液xが充填され、前部ガスケット5と後部ガ
スケット7との間が第2液室Yとなり、第2薬液yが充
填される。すなわち、製造してから使用するまでの間
は、この図示の状態で保管される。なお、使用される薬
液の種類は種々あるが、第1薬液xとして麻酔薬を用い
るときは第2薬液yとして高粘性薬液を用い、第1薬液
xとしてブドウ糖液を用いるときは第2薬液yとしてア
ミノ酸液を用いるのが代表的である。
Since the prefilled syringe A of this embodiment is a two-liquid type, as shown in the figure, the front gasket 5 is inserted in the approximate center of the syringe outer cylinder 1, and the rear gasket 7 is the rear end of the syringe outer cylinder 1. Inserted in. Then, the space between the front gasket 5 and the injection needle mounting member 2 becomes the first liquid chamber X, the first chemical liquid x is filled, and the space between the front gasket 5 and the rear gasket 7 becomes the second liquid chamber Y, The second chemical liquid y is filled. That is, it is stored in the illustrated state from the time it is manufactured until it is used. There are various kinds of chemicals to be used, but when an anesthetic is used as the first chemical x, a highly viscous chemical is used as the second chemical y, and when a glucose solution is used as the first chemical x, the second chemical y is used. It is typical to use an amino acid solution as.

【0013】つぎに、本実施例のプレフィルドシリンジ
Aの操作方法等を第1薬液xとして麻酔薬を、第2薬液
として高粘性薬液を用いた場合について説明する。図5
に示す保管状態において、ゴムキャップ26と後端カバー
44を取外し、図1に示すように、ルアーチップ24に注射
針8を取付け、後部ガスケット7にプランジャー9を取
付ける。前記注射針8は、一般的な注射針であり、ハブ
81にカヌラ82が取付けられ、ハブ81の後端外周には雄ネ
ジ部83が形成されている。したがって、雌ネジ筒25にね
じ込むことにより注射針8をしっかりと固定できる。な
お、嵌合型の結合構造であれば、ルアーチップ24に注射
針8のハブをしっかりと挿入し、あるいはさらに回転さ
せて固定すればよい。前記プランジャー9は公知のもの
であり、ロッド91の前端に雄ネジ部92が形成され、後端
に指当部93が形成されている。このプランジャー9の雄
ネジ部9を後部ガスケット7の雌ネジ部72にねじ込むこ
とにより、しっかりと互いに結合することができる。
Next, a method of operating the prefilled syringe A of this embodiment will be described with reference to the case where an anesthetic is used as the first chemical liquid x and a highly viscous chemical liquid is used as the second chemical liquid. Figure 5
In the storage state shown in, the rubber cap 26 and the rear end cover
44 is removed, the injection needle 8 is attached to the luer tip 24, and the plunger 9 is attached to the rear gasket 7, as shown in FIG. The injection needle 8 is a general injection needle and has a hub.
A canula 82 is attached to 81, and a male screw portion 83 is formed on the outer periphery of the rear end of the hub 81. Therefore, the injection needle 8 can be firmly fixed by screwing it into the female screw cylinder 25. In the case of a fitting type coupling structure, the hub of the injection needle 8 may be firmly inserted into the luer tip 24, or further rotated and fixed. The plunger 9 is a known one, and a male screw portion 92 is formed at the front end of the rod 91, and a finger rest portion 93 is formed at the rear end. By screwing the male screw portion 9 of the plunger 9 into the female screw portion 72 of the rear gasket 7, they can be firmly coupled to each other.

【0014】上記により注射の準備が完了であり、シリ
ンジ外筒1とプランジャー9を片手で持ち、人差指と中
指をフランジ4に引掛け、親指でプランジャー9を押す
と、第2薬液yは液体の非圧縮性を有するため前部ガス
ケット5は後部ガスケット7との間の距離を保ったまま
前方へ押されていく。この結果、前部ガスケット5より
前方の第1薬液xが注射針8から患者の体内へ直接注射
される。
When the preparation for injection is completed as described above, the syringe outer cylinder 1 and the plunger 9 are held with one hand, the index finger and the middle finger are hooked on the flange 4, and the plunger 9 is pushed with the thumb. Due to the incompressibility of the liquid, the front gasket 5 is pushed forward while maintaining the distance from the rear gasket 7. As a result, the first drug solution x in front of the front gasket 5 is directly injected into the patient's body from the injection needle 8.

【0015】上記のようにして第1薬液xがほとんど排
出される状態に至ると、図2に示すように、前部ガスケ
ット5はシリンジ外筒1の先端部に位置し、その前方収
容部53内の閉鎖体6が閉鎖体押出部材3に当接する。こ
の状態から、さらにプランジャー9を押し込むと、前部
ガスケット5の栓体51のみが前進するので、閉鎖体6は
矢印cで示すように後方収容室54内へ移動する。図3は
この移動が完了した状態であり、このように閉鎖体6の
後方収容室54への移動が完了すると、前部ガスケット5
のバイパス路55は閉鎖体押出部材3の開口31を通じて注
射針取付部材2の薬液通路27と連通する。このため、さ
らにプランジャー9を押し込むと、第2薬液yを注射針
8から患者の体内へ直接注射することができる。最後ま
でプランジャー9を押し込むと、図4に示すように後部
ガスケット7が前部ガスケット5の後端に当って止ま
り、全ての薬液の注射を完了する。
When most of the first chemical liquid x is discharged as described above, the front gasket 5 is located at the tip of the syringe outer cylinder 1 and the front accommodation portion 53 thereof, as shown in FIG. The inner closing body 6 contacts the closing body pushing member 3. When the plunger 9 is further pushed in from this state, only the plug body 51 of the front gasket 5 advances, so that the closing body 6 moves into the rear storage chamber 54 as shown by the arrow c. FIG. 3 shows a state in which this movement is completed, and when the movement of the closing body 6 to the rear storage chamber 54 is completed in this manner, the front gasket 5
The bypass passage 55 communicates with the liquid medicine passage 27 of the injection needle mounting member 2 through the opening 31 of the closing body pushing member 3. Therefore, by further pushing the plunger 9, the second drug solution y can be directly injected into the patient's body from the injection needle 8. When the plunger 9 is pushed all the way in, the rear gasket 7 abuts on the rear end of the front gasket 5 and stops, as shown in FIG. 4, and injection of all the drug solution is completed.

【0016】注射を終えた後は、注射針8をねじ戻して
注射針取付部材2から取り外せば、注射針8とシリンジ
本体側との分別廃棄を容易に行える。なお、第1薬液と
してブドウ糖液を、第2薬液としてアミノ酸液を用いた
場合については、同様の操作で、混合用バッグに注入
し、このバッグで混合してから点滴治療に使用される。
After the injection is finished, if the injection needle 8 is unscrewed and removed from the injection needle mounting member 2, the injection needle 8 and the syringe body side can be easily separated and discarded. When a glucose solution is used as the first chemical solution and an amino acid solution is used as the second chemical solution, the mixture is injected into a mixing bag by the same operation and mixed in this bag before being used for drip therapy.

【0017】つぎに、本発明の他の実施例を説明する。
図6は本発明の他の実施例に係る1液型のプレフィルド
シリンジBの前部ガスケット開栓操作の説明図、図7は
薬液注射操作の説明図、図8は使用前の保管状態におけ
る同プレフィルドシリンジBの縦断面図である。
Next, another embodiment of the present invention will be described.
6 is an explanatory view of a front gasket opening operation of a one-pack type prefilled syringe B according to another embodiment of the present invention, FIG. 7 is an explanatory view of a drug solution injection operation, and FIG. 8 is the same in a storage state before use. It is a longitudinal cross-sectional view of the prefilled syringe B.

【0018】図8に示すように、本実施例のプレフィル
ドシリンジBの各部の構成は図5に示す前記実施例のプ
レフィルドシリンジAと実質的に同一である。相違する
点は、前部ガスケット5と注射針取付部材2との間に薬
液を充填せず、前部ガスケット5と後部ガスケット7と
の間にのみ一種類の薬液zを充填している点である。薬
液zの種類としては、前記2液型と異なりとくに制限さ
れず、種々の薬液が用いられる。したがって、同一部品
に同一符号を付して重複した説明は省略する。なお、本
実施例において、通常、前部ガスケット5はシリンジ外
筒1内の前端位置に最初から挿入され、後部ガスケット
7との間の薬液充填体積を大きくするようにされる。
As shown in FIG. 8, the structure of each part of the prefilled syringe B of this embodiment is substantially the same as that of the prefilled syringe A of the above embodiment shown in FIG. The difference is that the liquid medicine is not filled between the front gasket 5 and the injection needle mounting member 2, but one kind of liquid medicine z is filled only between the front gasket 5 and the rear gasket 7. is there. Unlike the two-liquid type, the type of the chemical liquid z is not particularly limited, and various chemical liquids can be used. Therefore, the same reference numerals are given to the same components and duplicated description will be omitted. In the present embodiment, the front gasket 5 is usually inserted from the beginning into the front end position in the syringe outer cylinder 1 so as to increase the drug solution filling volume between the front gasket 5 and the rear gasket 7.

【0019】つぎに、本実施例のプレフィルドシリンジ
Bにおける注射操作を説明する。まず、先の実施例と同
様に、ゴムキャップ26と後端カバー44を取外し、図6に
示すようにルアーチップ24に注射針8を取付け、後部ガ
スケット7にプランジャー9を結合する。そして、プラ
ンジャー9を押し込む。この最初のプランジャー9の押
し込み操作により、前部ガスケット5が前進し、閉鎖体
6は閉鎖体押出部材3に当っているので前進できず、相
対的に閉鎖体6は矢印cで示すように前方収容部53から
後方収容部54へ移動する。この移動が完了した状態が図
7であり、閉鎖体6の後方収容室54への移動が完了する
と、前部ガスケット5のバイパス路55は閉鎖体押出部材
3の開口31を通じて注射針取付部材2の薬液通路27と連
通する。このため、さらにプランジャー9を押し込む
と、薬液zを注射針8から患者の体内へ注射することが
できる。最後までプランジャー9を押し込むと、後部ガ
スケット7が前部ガスケット5の後端に当って止まり、
薬液の全量の注射を完了する。注射を終えた後は、注射
針8をねじ戻して注射針取付部材2から取り外せば、注
射針8とシリンジ本体側との分別廃棄を容易に行える。
Next, the injection operation of the prefilled syringe B of this embodiment will be described. First, as in the previous embodiment, the rubber cap 26 and the rear end cover 44 are removed, the injection needle 8 is attached to the luer tip 24, and the plunger 9 is connected to the rear gasket 7 as shown in FIG. Then, the plunger 9 is pushed in. By the first pushing operation of the plunger 9, the front gasket 5 advances, and the closing body 6 cannot move forward because it is in contact with the closing body pushing member 3, so that the closing body 6 relatively moves as shown by an arrow c. It moves from the front accommodation part 53 to the rear accommodation part 54. FIG. 7 shows a state in which this movement is completed. When the movement of the closing body 6 to the rear accommodation chamber 54 is completed, the bypass passage 55 of the front gasket 5 passes through the opening 31 of the closing body pushing member 3 and the injection needle mounting member 2 is inserted. Communicates with the chemical liquid passage 27. Therefore, when the plunger 9 is further pushed, the drug solution z can be injected into the patient's body from the injection needle 8. When the plunger 9 is pushed all the way in, the rear gasket 7 hits the rear end of the front gasket 5 and stops,
Complete the injection of the full volume of drug solution. After the injection is finished, if the injection needle 8 is unscrewed and removed from the injection needle mounting member 2, the injection needle 8 and the syringe body side can be easily separated and discarded.

【0020】[0020]

【発明の効果】本発明によれば、製造が容易で低コスト
であり、大容量タイプも製造可能であり、コアリングが
全く生じず、注射針の分別廃棄も可能なプレフィルドシ
リンジを提供できる。また、本発明は2液型としても1
液型としても利用できる兼用型のプレフィルドシリンジ
を提供することができる。
According to the present invention, it is possible to provide a prefilled syringe which is easy to manufacture, low in cost, capable of manufacturing a large-capacity type, does not cause coring at all, and is capable of separating and discarding injection needles. In addition, the present invention is also applicable to a two-pack type
It is possible to provide a dual-use prefilled syringe that can also be used as a liquid type.

【図面の簡単な説明】[Brief description of drawings]

【図1】本発明の一実施例に係る2液型のプレフィルド
シリンジAの第1薬液注射操作の説明図である。
FIG. 1 is an explanatory diagram of a first liquid medicine injection operation of a two-liquid type prefilled syringe A according to an embodiment of the present invention.

【図2】同プレフィルドシリンジAの前部ガスケット開
栓操作の説明図である。
FIG. 2 is an explanatory diagram of a front gasket opening operation of the same prefilled syringe A.

【図3】同プレフィルドシリンジAの第2薬液注射操作
の説明図である。
FIG. 3 is an explanatory diagram of a second chemical solution injection operation of the prefilled syringe A.

【図4】同プレフィルドシリンジAの注射完了状態の説
明図である。
FIG. 4 is an explanatory diagram of an injection completed state of the prefilled syringe A.

【図5】使用前の保管状態における同プレフィルドシリ
ンジAの縦断面図である。
FIG. 5 is a vertical sectional view of the prefilled syringe A in a storage state before use.

【図6】本発明の他の実施例に係る1液型のプレフィル
ドシリンジBの前部ガスケット開栓操作の説明図であ
る。
FIG. 6 is an explanatory diagram of a front gasket opening operation of the one-liquid type prefilled syringe B according to another embodiment of the present invention.

【図7】同プレフィルドシリンジBの薬液注射操作の説
明図である。
FIG. 7 is an explanatory diagram of a drug solution injection operation of the prefilled syringe B.

【図8】使用前の保管状態における同プレフィルドシリ
ンジBの縦断面図である。
FIG. 8 is a vertical cross-sectional view of the prefilled syringe B in the storage state before use.

【図9】従来例Iのプレフィルドシリンジの説明図であ
る。
9 is an explanatory diagram of a prefilled syringe of Conventional Example I. FIG.

【図10】従来例IIのプレフィルドシリンジの説明図であ
る。
FIG. 10 is an explanatory diagram of a prefilled syringe of Conventional Example II.

【符号の説明】[Explanation of symbols]

1 シリンジ外筒 2 注射針取
付部材 3 閉鎖体押出部材 4 フランジ 5 前部ガスケット 6 閉鎖体 7 後部ガスケット 8 注射針 9 プランジャー
1 Syringe outer cylinder 2 Injection needle mounting member 3 Closure body push-out member 4 Flange 5 Front gasket 6 Closure body 7 Rear gasket 8 Injection needle 9 Plunger

Claims (3)

【特許請求の範囲】[Claims] 【請求項1】両端が開口したシリンジ外筒と、前記シリ
ンジ外筒の前端に設けられた注射針取付部材と、前記シ
リンジ外筒の内部に液密に挿入された、閉鎖体を内蔵し
た前部ガスケットと、前記シリンジ外筒の後端部に液密
に挿入された、プランジャーを取付自在な後部ガスケッ
トと、前記注射針取付部材の後端に取付けた閉鎖体押出
手段とからなり、前記前部ガスケットには、軸方向に貫
通する薬液通路と、該薬液通路の前方部に前記閉鎖体を
収容して該薬液通路を閉鎖する前方収容部と、該薬液通
路の後方部に前記閉鎖体を収容する後方収容部と、該後
方収容部を迂回し前記前方収容部と連通するバイパス路
とが形成されており、前記閉鎖体押出手段は、前記前部
ガスケットがシリンジ外筒内の前端部に押し込まれたと
き、前部ガスケットの前方収容部内の前記閉鎖体に当接
して、これを後方収容部内に押し出す部材であることを
特徴とするプレフィルドシリンジ。
1. A syringe outer cylinder having both ends opened, an injection needle mounting member provided at a front end of the syringe outer cylinder, and a closed body which is liquid-tightly inserted into the syringe outer cylinder. A part gasket, a rear gasket that is liquid-tightly inserted into the rear end of the syringe outer cylinder and can be fitted with a plunger, and a closing body pushing means attached to the rear end of the injection needle mounting member, The front gasket includes an axially penetrating chemical liquid passage, a front accommodating portion for accommodating the closing body to close the chemical liquid passage at a front portion of the chemical liquid passage, and a closing body at a rear portion of the chemical liquid passage. Is formed, and a bypass path that bypasses the rear housing portion and communicates with the front housing portion is formed, and in the closing body pushing means, the front gasket is a front end portion inside the syringe outer cylinder. Front gasket when pushed into Of contact with the closure body in the front housing portion, a pre-filled syringe, characterized in that it is a member for pushing the rear housing portion.
【請求項2】前記シリンジ外筒の前端と前部ガスケット
の間に第1薬液を充填し、前部ガスケットと後部ガスケ
ットの間に第2薬液を充填して用いる2液型の請求項1
記載のプレフィルドシリンジ。
2. A two-liquid type in which a first chemical liquid is filled between the front end and the front gasket of the syringe outer cylinder, and a second chemical liquid is filled between the front gasket and the rear gasket.
The prefilled syringe described.
【請求項3】前記シリンジ外筒において前部ガスケット
と後部ガスケットの間に第1薬液を充填して用いる1液
型の請求項1記載のプレフィルドシリンジ。
3. The prefilled syringe according to claim 1, which is a one-liquid type in which a first chemical liquid is filled between a front gasket and a rear gasket in the syringe outer cylinder.
JP12596495A 1995-04-25 1995-04-25 Prefilled syringe Expired - Fee Related JP3419145B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP12596495A JP3419145B2 (en) 1995-04-25 1995-04-25 Prefilled syringe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP12596495A JP3419145B2 (en) 1995-04-25 1995-04-25 Prefilled syringe

Publications (2)

Publication Number Publication Date
JPH08294532A true JPH08294532A (en) 1996-11-12
JP3419145B2 JP3419145B2 (en) 2003-06-23

Family

ID=14923344

Family Applications (1)

Application Number Title Priority Date Filing Date
JP12596495A Expired - Fee Related JP3419145B2 (en) 1995-04-25 1995-04-25 Prefilled syringe

Country Status (1)

Country Link
JP (1) JP3419145B2 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002011793A1 (en) * 2000-08-08 2002-02-14 Medical Information Services, Inc. Kit preparation syringe, intermediate slide valve for syringes, and kit preparation
WO2003045478A1 (en) * 2001-11-27 2003-06-05 Terumo Kabushiki Kaisha Two-chamber type prefilled syringe
JP2004538043A (en) * 2001-03-27 2004-12-24 ラボラトワール ドゥ コンタクトロジー アプリケ―エルセーアー Syringe for injecting viscoelastic solutions
JP2005027805A (en) * 2003-07-10 2005-02-03 Nemoto Kyorindo:Kk Syringe for liquid medicine
WO2005072644A1 (en) 2004-02-02 2005-08-11 Bimeda Research & Development Limited Method and device for treating a teat canal of an animal
JP2007508898A (en) * 2003-10-23 2007-04-12 メリディアン メディカル テクノロジーズ,インコーポレーテッド Wet / dry automatic syringe assembly
JP2007535987A (en) * 2004-05-03 2007-12-13 インヒュースィヴ・テクノロジーズ・エルエルシー Multi-chamber sequential dose dispensing syringe
JP2010540122A (en) * 2007-09-27 2010-12-24 ベクトン・ディキンソン・アンド・カンパニー Cartridge for powder and liquid drugs
JP2011056285A (en) * 2000-07-22 2011-03-24 E-Wha Fresenius Kabi Inc Liquid supply apparatus
JP2012530579A (en) * 2009-06-25 2012-12-06 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Prefilled cannula assembly
US9180249B2 (en) 2004-02-02 2015-11-10 Bimeda Research & Development Limited Method and device
US9694134B2 (en) 2013-09-16 2017-07-04 Zoetis Services Llc Assembly for sequentially delivering substances, and associated methods

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011056285A (en) * 2000-07-22 2011-03-24 E-Wha Fresenius Kabi Inc Liquid supply apparatus
JP2012250088A (en) * 2000-07-22 2012-12-20 E-Wha Fresenius Kabi Inc Liquid supply device
WO2002011793A1 (en) * 2000-08-08 2002-02-14 Medical Information Services, Inc. Kit preparation syringe, intermediate slide valve for syringes, and kit preparation
US8568367B2 (en) 2000-10-10 2013-10-29 Meridian Medical Technologies, Inc. Needle assemblies for wet/dry automatic injectors
JP2004538043A (en) * 2001-03-27 2004-12-24 ラボラトワール ドゥ コンタクトロジー アプリケ―エルセーアー Syringe for injecting viscoelastic solutions
WO2003045478A1 (en) * 2001-11-27 2003-06-05 Terumo Kabushiki Kaisha Two-chamber type prefilled syringe
JP2005027805A (en) * 2003-07-10 2005-02-03 Nemoto Kyorindo:Kk Syringe for liquid medicine
JP2007508898A (en) * 2003-10-23 2007-04-12 メリディアン メディカル テクノロジーズ,インコーポレーテッド Wet / dry automatic syringe assembly
JP2010162414A (en) * 2003-10-23 2010-07-29 Meridian Medical Technologies Inc Automatic injector and method of assembling the same
JP4896727B2 (en) * 2003-10-23 2012-03-14 メリディアン メディカル テクノロジーズ,インコーポレーテッド Wet / dry automatic syringe assembly
WO2005072644A1 (en) 2004-02-02 2005-08-11 Bimeda Research & Development Limited Method and device for treating a teat canal of an animal
EP1718237A1 (en) * 2004-02-02 2006-11-08 Bimeda Research And Development Limited A method and device for treating a teat canal of an animal
US9180249B2 (en) 2004-02-02 2015-11-10 Bimeda Research & Development Limited Method and device
JP2007535987A (en) * 2004-05-03 2007-12-13 インヒュースィヴ・テクノロジーズ・エルエルシー Multi-chamber sequential dose dispensing syringe
JP2010540122A (en) * 2007-09-27 2010-12-24 ベクトン・ディキンソン・アンド・カンパニー Cartridge for powder and liquid drugs
JP2012530579A (en) * 2009-06-25 2012-12-06 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Prefilled cannula assembly
US9694134B2 (en) 2013-09-16 2017-07-04 Zoetis Services Llc Assembly for sequentially delivering substances, and associated methods

Also Published As

Publication number Publication date
JP3419145B2 (en) 2003-06-23

Similar Documents

Publication Publication Date Title
US4084588A (en) Parenteral drug storage device with closure piercing coupling member
EP0191508B1 (en) Syringe
US4226236A (en) Prefilled, vented two-compartment syringe
JP2801207B2 (en) Syringe and method of assembling syringe
JP3591636B2 (en) Prefilled syringe
US3872864A (en) Double syringe
US5755696A (en) Syringe filling and delivery device
EP0609741B1 (en) Prefilled syringe assembly
JP3083134B2 (en) Cannula sealed shield assembly
US4153057A (en) Stopper for two-chamber mixing syringe
EP1378223A1 (en) Drug solution container with a connector for communicating
JPS6258745B2 (en)
US20030125671A1 (en) Syringe-type container for liquid medicine
JP2001112867A (en) Syringe containing drug
JP2011025066A (en) Self-sealing male connector
JPH1057503A (en) Fluid transfer device for accessing fluid from vial and ampoule, and fluid transfer method using the device
JP3419145B2 (en) Prefilled syringe
KR100198363B1 (en) Drug vessel
WO2018173925A1 (en) Female syringe and syringe kit
IE921229A1 (en) Device for the administration of drugs
JP2002078799A (en) Liquid injection appliance
JPH07246238A (en) Injector assembly
JP3668293B2 (en) Injection container
JP4144027B2 (en) Two-component prefilled syringe
JP3175136B2 (en) Automatic syringe

Legal Events

Date Code Title Description
R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120418

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120418

Year of fee payment: 9

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150418

Year of fee payment: 12

LAPS Cancellation because of no payment of annual fees